Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Dec 22, 2020
Targets & Mechanisms
Tissue-targeting autoantibodies as a driver of long COVID
...immune cell surface markers; proteins expressed on
vascular
...
Read More
BioCentury
|
Dec 17, 2020
Product Development
Two non-amyloid therapies for Alzheimer’s advance to late-stage trials
...the immunoglobulin-like cell surface receptor RAGE, contributes to
vascular
...
Read More
BioCentury
|
Dec 10, 2020
Product Development
Vaccines aren’t enough: COVID R&D’s adaptive platform trial aims to fill the need for new therapies
...continue adding new therapies including antivirals and
vascular
...
...peptides. Bradykinins have been shown to cause
vascular
...
Read More
BioCentury
|
Dec 5, 2020
Product Development
Dec. 4 Quick Takes: Zogenix in Dravet deal with start-up; plus updates from BioCryst, Takeda, AB Science, Sutro, Lilly, Cedars-Sinai
...with the facility to manufacture banks of stem cells that could be used to repair
vascular
...
Read More
BioCentury
|
Nov 25, 2020
Product Development
Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia
...The company also said Charles Semba has joined as CMO. Semba is an adjunct professor of
vascular
...
Read More
BioCentury
|
Nov 14, 2020
Regulation
BioMarin withdraws MAA for hemophilia gene therapy following safety, durability concerns
...1 IFNγ – Interferon γIL-3 – Interleukin-3VEGF –
Vascular
...
Read More
BioCentury
|
Nov 14, 2020
Deals
Innovation in a hurry: China biotechs see a fast track to global stage – survey
...CD279) – Programmed cell death 1VEGF –
Vascular
...
Read More
BioCentury
|
Nov 11, 2020
Emerging Company Profile
CatalYm: opening up tumors to immune cells
...inhibits LFA-1 activation on immune cells. This prevents LFA-1 from interacting with ICAM-1 on the
vascular
...
Read More
BioCentury
|
Oct 30, 2020
Product Development
José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy
...Tumor-associated calcium signal transducer 2VEGF -
Vascular
...
Read More
BioCentury
|
Oct 30, 2020
Distillery Therapeutics
Targeting water channel AQP1 for hypertrophic cardiomyopathy
...Quang, Staff Writer DISEASE CATEGORY: Cardio
vascular
INDICATION: CardiomyopathyInhibiting AQP1, a water channel expressed in cardiac and
vascular
...
Read More
Items per page:
10
1 - 10 of 4500
BioCentury
|
Dec 22, 2020
Targets & Mechanisms
Tissue-targeting autoantibodies as a driver of long COVID
...immune cell surface markers; proteins expressed on
vascular
...
Read More
BioCentury
|
Dec 17, 2020
Product Development
Two non-amyloid therapies for Alzheimer’s advance to late-stage trials
...the immunoglobulin-like cell surface receptor RAGE, contributes to
vascular
...
Read More
BioCentury
|
Dec 10, 2020
Product Development
Vaccines aren’t enough: COVID R&D’s adaptive platform trial aims to fill the need for new therapies
...continue adding new therapies including antivirals and
vascular
...
...peptides. Bradykinins have been shown to cause
vascular
...
Read More
BioCentury
|
Dec 5, 2020
Product Development
Dec. 4 Quick Takes: Zogenix in Dravet deal with start-up; plus updates from BioCryst, Takeda, AB Science, Sutro, Lilly, Cedars-Sinai
...with the facility to manufacture banks of stem cells that could be used to repair
vascular
...
Read More
BioCentury
|
Nov 25, 2020
Product Development
Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia
...The company also said Charles Semba has joined as CMO. Semba is an adjunct professor of
vascular
...
Read More
BioCentury
|
Nov 14, 2020
Regulation
BioMarin withdraws MAA for hemophilia gene therapy following safety, durability concerns
...1 IFNγ – Interferon γIL-3 – Interleukin-3VEGF –
Vascular
...
Read More
BioCentury
|
Nov 14, 2020
Deals
Innovation in a hurry: China biotechs see a fast track to global stage – survey
...CD279) – Programmed cell death 1VEGF –
Vascular
...
Read More
BioCentury
|
Nov 11, 2020
Emerging Company Profile
CatalYm: opening up tumors to immune cells
...inhibits LFA-1 activation on immune cells. This prevents LFA-1 from interacting with ICAM-1 on the
vascular
...
Read More
BioCentury
|
Oct 30, 2020
Product Development
José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy
...Tumor-associated calcium signal transducer 2VEGF -
Vascular
...
Read More
BioCentury
|
Oct 30, 2020
Distillery Therapeutics
Targeting water channel AQP1 for hypertrophic cardiomyopathy
...Quang, Staff Writer DISEASE CATEGORY: Cardio
vascular
INDICATION: CardiomyopathyInhibiting AQP1, a water channel expressed in cardiac and
vascular
...
Read More
Items per page:
10
1 - 10 of 4500
Previous page
Next page